• Mon news: Pfizer wins legal patent battle over GSK. Hospitals face hurricane-induced IV shortages. Activist investor takes $1B stake in Pfizer. MicroRNA pioneers win Nobel. Jude Bio debuts with $100M. See more on our front page

Xolair label change


<







Not from Genentech, just read the media announcement:

"...5 yr study showed higher risk of heart attack, mini-stroke, chest pain and blood clots in lung and veins (pulmonary hypertension)....extent of increased risk is unclear, due to study design....cannot rule out potential cancer risk".

Absolutely nothing positive mentioned. Based on above, don't see how this could be a good thing.
 




Similar threads

Replies
4
Views
2K
Replies
2
Views
2K
Replies
6
Views
4K
Replies
12
Views
4K
Replies
9
Views
4K